“I support immunology and immunotherapy research because it is one of the few levers we have that can fundamentally change the trajectory of cancer and many immune‑driven diseases in a single generation. Sustained investment is essential to turn today’s high‑risk ideas into tomorrow’s standard, accessible treatments for California patients.”
